Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
US5972377A · kind A · utility
55Cited by
7References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 1998 |
| Grant date | Oct 26, 1999 |
| Priority date | — |
| Expiry date | Oct 2, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for preventing ovulation in a woman are provided, as well as compositions and methods for female hormone replacement therapy. The compositions can be administered by the use of a transdermal patch. The patch will administer 17-deacetyl norgestimate alone or in combination with an estrogen such as ethinyl estradiol to women.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.